Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Glaxo Wellcome describes new agents for CMV

Sep. 29, 1997

Schering-Plough and Genome Therapeutics enter antifungal alliance

Sep. 26, 1997

Phase III trial of Neuprex in meningococcemia continues; pilot trial in CF begins

Sep. 25, 1997

LY-303366: efficacy in rabbits with invasive pulmonary aspergillosis

Sep. 25, 1997

Famvir approved by FDA for new indication

Sep. 22, 1997

Vaxar: first launch for new fluoroquinolone

Sep. 22, 1997

Phase I results reported for MiKasome

Sep. 22, 1997

New cephalosporins from Il-Dong

Sep. 19, 1997

Searle evaluates novel target for antifungal agents

Sep. 17, 1997

Antiviral benzimidazole compounds prepared at Glaxo Wellcome

Sep. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...